BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 7966218)

  • 1. The effect of topical antimicrobial agents on the production of toxic shock syndrome toxin-1.
    Edwards-Jones V; Foster HA
    J Med Microbiol; 1994 Dec; 41(6):408-13. PubMed ID: 7966218
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of silver sulphadiazine on the production of exoproteins by Staphylococcus aureus.
    Edwards-Jones V; Foster HA
    J Med Microbiol; 2002 Jan; 51(1):50-55. PubMed ID: 11800472
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of trace metals on the synthesis of toxic shock syndrome toxin 1.
    Reeves MW
    Rev Infect Dis; 1989; 11 Suppl 1():S145-49; discussion S149-50. PubMed ID: 2928630
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The effect of magnesium on the formation of toxic shock syndrome toxin 1 (TSST-1) by Staphylococcus aureus].
    Dickgiesser N; Wallach U
    Zentralbl Bakteriol Mikrobiol Hyg A; 1987 Mar; 263(4):572-6. PubMed ID: 3111133
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Co-production of staphylococcal enterotoxin A with toxic shock syndrome toxin-1 (TSST-1) enhances TSST-1 mediated mortality in a D-galactosamine sensitized mouse model of lethal shock.
    De Boer ML; Kum WW; Pang LT; Chow AW
    Microb Pathog; 1999 Aug; 27(2):61-70. PubMed ID: 10458917
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Toxic shock syndrome toxin-1 producing strains of Staphylococcus aureus in vaginal smears].
    Dickgiesser N; Brombacher A; Wiest W
    Geburtshilfe Frauenheilkd; 1987 Feb; 47(2):104-6. PubMed ID: 3569835
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Latex agglutination test for staphylococcal toxic shock syndrome toxin 1.
    Igarashi H; Fujikawa H; Shingaki M; Bergdoll MS
    J Clin Microbiol; 1986 Mar; 23(3):509-12. PubMed ID: 3082921
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Evidence of enterotoxins and toxic shock syndrome toxin (TSST-1) in strains of Staphylococcus aureus isolated from various biological materials].
    Simkovicová M; Hanzen J; Milosovic P; Lisálová M; Jakubovská M
    Epidemiol Mikrobiol Imunol; 2002 Aug; 51(3):102-6. PubMed ID: 12184187
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of the Today contraceptive sponge on growth and toxic shock syndrome toxin-1 production by Staphylococcus aureus.
    Remington KM; Buller RS; Kelly JR
    Obstet Gynecol; 1987 Apr; 69(4):563-9. PubMed ID: 3822297
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Staphylococcus aureus producing toxic shock syndrome toxin 1 (TSST-1) in clinical specimens and vaginal swabs in Mannheim, West Germany.
    Dickgiesser N; Brombacher A
    Zentralbl Bakteriol Mikrobiol Hyg A; 1987 Jul; 265(3-4):323-9. PubMed ID: 3314262
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The in-vitro activity of povidone-iodinecream against Staphylococcus aureus and its bioavailability in nasal secretions.
    Hill RL; Casewell MW
    J Hosp Infect; 2000 Jul; 45(3):198-205. PubMed ID: 10896798
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Toxic shock syndrome toxin-1 (TSST-1) production in staphylococcal infections and serological implications with patients and healthy controls.
    Naidu AS; Vörös S; Löczi G; Kienle Z; Brasch B; Emödy L
    Acta Microbiol Hung; 1989; 36(1):19-24. PubMed ID: 2603642
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Exanthematous disease induced by toxic shock syndrome toxin 1 in the early neonatal period.
    Takahashi N; Nishida H; Kato H; Imanishi K; Sakata Y; Uchiyama T
    Lancet; 1998 May; 351(9116):1614-9. PubMed ID: 9620715
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of type 8 capsular polysaccharide and production of toxic shock syndrome toxin 1 are associated among vaginal isolates of Staphylococcus aureus.
    Lee JC; Liu MJ; Parsonnet J; Arbeit RD
    J Clin Microbiol; 1990 Dec; 28(12):2612-5. PubMed ID: 2279990
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genotypic characterization of toxic shock syndrome toxin-1-producing strains of Staphylococcus aureus isolated in the Czech Republic.
    Hrstka R; Růzicková V; Petrás P; Pantůcek R; Rosypal S; Doskar J
    Int J Med Microbiol; 2006 Feb; 296(1):49-54. PubMed ID: 16423687
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Postoperative toxic shock syndrome caused by a highly virulent methicillin-resistant Staphylococcus aureus strain.
    Cui L; Kasegawa H; Murakami Y; Hanaki H; Hiramatsu K
    Scand J Infect Dis; 1999; 31(2):208-9. PubMed ID: 10447337
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Frequency of toxic-shock-syndrome-toxin producing strains of Staphylococcus aureus in the Basel region].
    Vischer WA; Stalder H; Faupel DM
    Schweiz Med Wochenschr; 1985 Aug; 115(35):1196-9. PubMed ID: 4048915
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Production of toxic shock syndrome toxin-1 (TSST-1) by Staphylococcus aureus strains isolated from humans, animals and foods in Nigeria.
    Adesiyun AA; Lenz W; Schaal KP
    Microbiologica; 1992 Apr; 15(2):125-33. PubMed ID: 1602983
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Production of toxic shock syndrome toxin-1 (TSST-1) associated with Staphylococcus aureus from a pyogenic skin infection.
    Naidu AS; Rathna K; Naidu S; Rao PN; Rajyalakshmi K
    Acta Microbiol Hung; 1988; 35(1):35-40. PubMed ID: 3394489
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Levels of toxic shock syndrome toxin-1 production among Staphylococcus aureus strains and clinical implications.
    Naidu AS; Kamme C; Ljungh A; Wadström T
    Zentralbl Bakteriol Mikrobiol Hyg A; 1989 Jan; 270(3):337-44. PubMed ID: 2648709
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.